# Optimal End-Tidal (ET) Sevoflurane and Desflurane Concentration for Extubation of Supreme Laryngeal Mask Airway (LMA) in Adults

> **NCT01083953** · NA · COMPLETED · sponsor: **University of Malaya** · enrollment: 54 (actual)

## Conditions studied

- Airway Complications

## Interventions

- **DRUG:** Sevoflurane
- **DRUG:** Desflurane

## Key facts

- **NCT ID:** NCT01083953
- **Lead sponsor:** University of Malaya
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2015-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01083953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01083953, "Optimal End-Tidal (ET) Sevoflurane and Desflurane Concentration for Extubation of Supreme Laryngeal Mask Airway (LMA) in Adults". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01083953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*